Ovid Therapeutics
OVID
#9100
Rank
A$0.17 B
Marketcap
A$2.44
Share price
-1.21%
Change (1 day)
57.82%
Change (1 year)

Ovid Therapeutics (OVID) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$28.61 Million

According to Ovid Therapeutics 's latest financial reports the company's total liabilities are A$28.61 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Ovid Therapeutics - Total liabilities on balance sheet (from 2016 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$38.49 M-53.36%
2023-12-31A$82.53 M144.26%
2022-12-31A$33.78 M65.53%
2021-12-31A$20.41 M-51.4%
2020-12-31A$41.99 M171.76%
2019-12-31A$15.45 M23.1%
2018-12-31A$12.55 M62.79%
2017-12-31A$7.71 M48.91%
2016-12-31A$5.17 M63.4%
2015-12-31A$3.16 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ORIC Pharmaceuticals
ORIC
A$36.27 M 26.75%๐Ÿ‡บ๐Ÿ‡ธ USA